Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)Mark F. Bird, David G. Lambert, Maria Camilla Cerlesi et al.|PLoS ONE|2016Cited by 55
<i>In vitro</i> and <i>in vivo</i> pharmacological characterization of nociceptin/orphanin <scp>FQ</scp> tetrabranched derivativesA. Rizzi, Girolamo Calò, Erika Marzola et al.|British Journal of Pharmacology|2014Cited by 33
In vitro pharmacological characterization of a novel unbiased <scp>NOP</scp> receptor‐selective nonpeptide agonist <scp>AT</scp>‐403Federica Ferrari, Nurulain T. Zaveri, Davide Malfacini et al.|Pharmacology Research & Perspectives|2017Cited by 31
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)Maria Camilla Cerlesi, Remo Guerrini, Huiping Ding et al.|European Journal of Pharmacology|2016Cited by 27
Nociceptin/Orphanin <scp>FQ</scp> (N/OFQ) conjugated to <scp>ATTO</scp>594: a novel fluorescent probe for the N/OFQ (NOP) receptorMark F. Bird, David G. Lambert, Renzo Guerrini et al.|British Journal of Pharmacology|2018Cited by 22